The Data and Safety Monitoring Board and Acquired immune deficiency syndrome (AIDS) clinical trials
Authors:
- Thomas R. FlemingTFThomas R. Fleming
- Richard J. WhitleyRWRichard J. Whitley
- James F. ChildressJCJames F. Childress
- Susan S. EllenbergSESusan S. Ellenberg
- Mary FoulkesMFMary Foulkes
- Kenneth H. MayerKMKenneth H. Mayer
- Judith O'FAllonJOJudith O'FAllon
- Richard B. PollardRPRichard B. Pollard
- James J. RahalJRJames J. Rahal
- Merle SandeMSMerle Sande
- Stephen StrausSSStephen Straus
Open Access
- 1 December 1995
- journal article
- Published by Elsevier in Controlled Clinical Trials
- Vol. 16 (6) , 408-421
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Concorde: MRC/ANRS randomised double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infectionThe Lancet, 1994
- Primary Prophylaxis with Pyrimethamine for Toxoplasmic Encephalitis in Patients with Advanced Human Immunodeficiency Virus Disease: Results of a Randomized TrialThe Journal of Infectious Diseases, 1994
- Data monitoring committees and capturing relevant information of high qualityStatistics in Medicine, 1993
- Interim analysis in clinical trialsStatistics in Medicine, 1991
- Zidovudine in Asymptomatic Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1990
- Conflict-of-Interest Guidelines for a Multicenter Clinical Trial of Treatment after Coronary-Artery Bypass-Graft SurgeryNew England Journal of Medicine, 1989
- The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987
- Discrete Sequential Boundaries for Clinical TrialsBiometrika, 1983
- Asymmetric group sequential boundaries for monitoring clinical trialsBiometrika, 1982
- A case report of data monitoring experience: The nocturnal oxygen therapy trialControlled Clinical Trials, 1982